74 related articles for article (PubMed ID: 30811996)
1. Unbiased Profiling of Isogenic Huntington Disease hPSC-Derived CNS and Peripheral Cells Reveals Strong Cell-Type Specificity of CAG Length Effects.
Ooi J; Langley SR; Xu X; Utami KH; Sim B; Huang Y; Harmston NP; Tay YL; Ziaei A; Zeng R; Low D; Aminkeng F; Sobota RM; Ginhoux F; Petretto E; Pouladi MA
Cell Rep; 2019 Feb; 26(9):2494-2508.e7. PubMed ID: 30811996
[TBL] [Abstract][Full Text] [Related]
2. Huntingtin HTT1a is generated in a CAG repeat-length-dependent manner in human tissues.
Hoschek F; Natan J; Wagner M; Sathasivam K; Abdelmoez A; von Einem B; Bates GP; Landwehrmeyer GB; Neueder A
Mol Med; 2024 Mar; 30(1):36. PubMed ID: 38459427
[TBL] [Abstract][Full Text] [Related]
3. Generation of three isogenic gene-edited Huntington's disease human embryonic stem cell lines with DOX-inducible NGN2 expression cassette in the AAVS1 safe locus.
Villegas LD; Chandrasekaran A; Andersen SAF; Nørremølle A; Schmid B; Pouladi MA; Freude K
Stem Cell Res; 2024 Jun; 77():103408. PubMed ID: 38569398
[TBL] [Abstract][Full Text] [Related]
4. Chromatin accessibility and transcription dynamics during in vitro astrocyte differentiation of Huntington's Disease Monkey pluripotent stem cells.
Goodnight AV; Kremsky I; Khampang S; Jung YH; Billingsley JM; Bosinger SE; Corces VG; Chan AWS
Epigenetics Chromatin; 2019 Nov; 12(1):67. PubMed ID: 31722751
[TBL] [Abstract][Full Text] [Related]
5. Introducing an expanded CAG tract into the huntingtin gene causes a wide spectrum of ultrastructural defects in cultured human cells.
Morozova KN; Suldina LA; Malankhanova TB; Grigor'eva EV; Zakian SM; Kiseleva E; Malakhova AA
PLoS One; 2018; 13(10):e0204735. PubMed ID: 30332437
[TBL] [Abstract][Full Text] [Related]
6. Precise CAG repeat contraction in a Huntington's Disease mouse model is enabled by gene editing with SpCas9-NG.
Oura S; Noda T; Morimura N; Hitoshi S; Nishimasu H; Nagai Y; Nureki O; Ikawa M
Commun Biol; 2021 Jun; 4(1):771. PubMed ID: 34163001
[TBL] [Abstract][Full Text] [Related]
7. Huntington disease affects mitochondrial network dynamics predisposing to pathogenic mtDNA mutations.
Neueder A; Kojer K; Gu Z; Wang Y; Hering T; Tabrizi S; Taanman JW; Orth M
Brain; 2024 Jan; ():. PubMed ID: 38195181
[TBL] [Abstract][Full Text] [Related]
8. A Phenotypic Atlas for Huntington Disease Based on Data From the Enroll-HD Cohort Study.
Langbehn DR; Sathe SS; Loy C; Sampaio C; Mccusker EA
Neurol Genet; 2023 Dec; 9(6):e200111. PubMed ID: 38035176
[TBL] [Abstract][Full Text] [Related]
9. Correction: Huntingtin HTT1a is generated in a CAG repeat-length-dependent manner in human tissues.
Hoschek F; Natan J; Wagner M; Sathasivam K; Abdelmoez A; Einem BV; Bates GP; Landwehrmeyer GB; Neueder A
Mol Med; 2024 Apr; 30(1):49. PubMed ID: 38600455
[No Abstract] [Full Text] [Related]
10. PIAS1 modulates striatal transcription, DNA damage repair, and SUMOylation with relevance to Huntington's disease.
Morozko EL; Smith-Geater C; Monteys AM; Pradhan S; Lim RG; Langfelder P; Kachemov M; Kulkarni JA; Zaifman J; Hill A; Stocksdale JT; Cullis PR; Wu J; Ochaba J; Miramontes R; Chakraborty A; Hazra TK; Lau A; St-Cyr S; Orellana I; Kopan L; Wang KQ; Yeung S; Leavitt BR; Reidling JC; Yang XW; Steffan JS; Davidson BL; Sarkar PS; Thompson LM
Proc Natl Acad Sci U S A; 2021 Jan; 118(4):. PubMed ID: 33468657
[TBL] [Abstract][Full Text] [Related]
11. Induced pluripotent stem cells derived from the developing striatum as a potential donor source for cell replacement therapy for Huntington disease.
Choompoo N; Bartley OJM; Precious SV; Vinh NN; Schnell C; Garcia A; Roberton VH; Williams NM; Kemp PJ; Kelly CM; Rosser AE
Cytotherapy; 2021 Feb; 23(2):111-118. PubMed ID: 33246883
[TBL] [Abstract][Full Text] [Related]
12. A Human Induced Pluripotent Stem Cell-Derived Isogenic Model of Huntington's Disease Based on Neuronal Cells Has Several Relevant Phenotypic Abnormalities.
Malankhanova T; Suldina L; Grigor'eva E; Medvedev S; Minina J; Morozova K; Kiseleva E; Zakian S; Malakhova A
J Pers Med; 2020 Nov; 10(4):. PubMed ID: 33182269
[TBL] [Abstract][Full Text] [Related]
13. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.
Cell; 1993 Mar; 72(6):971-83. PubMed ID: 8458085
[TBL] [Abstract][Full Text] [Related]
14. CHCHD2 up-regulation in Huntington disease mediates a compensatory protective response against oxidative stress.
Liu X; Wang F; Fan X; Chen M; Xu X; Xu Q; Zhu H; Xu A; Pouladi MA; Xu X
Cell Death Dis; 2024 Feb; 15(2):126. PubMed ID: 38341417
[TBL] [Abstract][Full Text] [Related]
15. Mutant huntingtin confers cell-autonomous phenotypes on Huntington's disease iPSC-derived microglia.
Stöberl N; Donaldson J; Binda CS; McAllister B; Hall-Roberts H; Jones L; Massey TH; Allen ND
Sci Rep; 2023 Nov; 13(1):20477. PubMed ID: 37993517
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide screening in pluripotent cells identifies Mtf1 as a suppressor of mutant huntingtin toxicity.
Ferlazzo GM; Gambetta AM; Amato S; Cannizzaro N; Angiolillo S; Arboit M; Diamante L; Carbognin E; Romani P; La Torre F; Galimberti E; Pflug F; Luoni M; Giannelli S; Pepe G; Capocci L; Di Pardo A; Vanzani P; Zennaro L; Broccoli V; Leeb M; Moro E; Maglione V; Martello G
Nat Commun; 2023 Jul; 14(1):3962. PubMed ID: 37407555
[TBL] [Abstract][Full Text] [Related]
17. Protocol Optimization for Direct Reprogramming of Primary Human Fibroblast into Induced Striatal Neurons.
Kraskovskaya N; Bolshakova A; Khotin M; Bezprozvanny I; Mikhailova N
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047770
[TBL] [Abstract][Full Text] [Related]
18. Integrative Meta-Analysis of Huntington's Disease Transcriptome Landscape.
Sneha NP; Dharshini SAP; Taguchi YH; Gromiha MM
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553652
[TBL] [Abstract][Full Text] [Related]
19. Huntington's disease iPSC models-using human patient cells to understand the pathology caused by expanded CAG repeats.
Kaye J; Reisine T; Finkbeiner S
Fac Rev; 2022; 11():16. PubMed ID: 35865413
[TBL] [Abstract][Full Text] [Related]
20. Standardization of Cell Culture Conditions and Routine Genomic Screening under a Quality Management System Leads to Reduced Genomic Instability in hPSCs.
Molina-Ruiz FJ; Introna C; Bombau G; Galofre M; Canals JM
Cells; 2022 Jun; 11(13):. PubMed ID: 35805069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
